6810 新穎生醫每月營收
| 年度/月份 | 營業收入 (單位:千元) | 累計營業收入 (單位:千元) |
|---|
| 單月營收 | 去年同月營收 | 單月月增率 | 單月年增率 | 累計營收 | 去年累計營收 | 累積年增率 |
|---|
| 2025/07 | 286 | 320 | 36.84% | -10.63% | 1,326 | 1,998 | -33.63% |
| 2025/06 | 209 | 381 | -1.42% | -45.14% | 1,040 | 1,678 | -38.02% |
| 2025/05 | 212 | 411 | 0.95% | -48.42% | 831 | 1,297 | -35.93% |
| 2025/04 | 210 | 439 | 6.60% | -52.16% | 619 | 886 | -30.14% |
| 2025/03 | 197 | 130 | 48.12% | 51.54% | 409 | 447 | -8.50% |
| 2025/02 | 133 | 130 | 68.35% | 2.31% | 212 | 317 | -33.12% |
| 2025/01 | 79 | 187 | -30.70% | -57.75% | 79 | 187 | -57.75% |
| 2024/12 | 114 | 13 | -98.82% | 776.92% | 12,297 | 1,208 | 917.96% |
| 2024/11 | 9,628 | 0 | 3675.69% | - | 12,183 | 1,195 | 919.50% |
| 2024/10 | 255 | 120 | 79.58% | 112.50% | 2,555 | 1,195 | 113.81% |
| 2024/09 | 142 | 125 | -11.25% | 13.60% | 2,300 | 1,075 | 113.95% |
| 2024/08 | 160 | 119 | -50.00% | 34.45% | 2,158 | 950 | 127.16% |
| 2024/07 | 320 | 111 | -16.01% | 188.29% | 1,998 | 831 | 140.43% |
| 2024/06 | 381 | 91 | -7.30% | 318.68% | 1,678 | 720 | 133.06% |
| 2024/05 | 411 | 297 | -6.38% | 38.38% | 1,297 | 629 | 106.20% |
| 2024/04 | 439 | 155 | 237.69% | 183.23% | 886 | 332 | 166.87% |
| 2024/03 | 130 | 8 | 0.00% | 1525.00% | 447 | 177 | 152.54% |
| 2024/02 | 130 | 128 | -30.48% | 1.56% | 317 | 169 | 87.57% |
| 2024/01 | 187 | 41 | 1338.46% | 356.10% | 187 | 41 | 356.10% |
| 2023/12 | 13 | 191 | - | -93.19% | 1,208 | 2,177 | -44.51% |
| 2023/11 | 0 | 17 | -100.00% | -100.00% | 1,195 | 1,986 | -39.83% |
| 2023/10 | 120 | 157 | -4.00% | -23.57% | 1,195 | 1,969 | -39.31% |
| 2023/09 | 125 | 135 | 5.04% | -7.41% | 1,075 | 1,812 | -40.67% |
| 2023/08 | 119 | 108 | 7.21% | 10.19% | 950 | 1,677 | -43.35% |
| 2023/07 | 111 | 517 | 21.98% | -78.53% | 831 | 1,569 | -47.04% |
| 2023/06 | 91 | 451 | -69.36% | -79.82% | 720 | 1,052 | -31.56% |
| 2023/05 | 297 | 84 | 91.61% | 253.57% | 629 | 601 | 4.66% |
| 2023/04 | 155 | 8 | 1837.50% | 1837.50% | 332 | 517 | -35.78% |
| 2023/03 | 8 | 3 | -93.75% | 166.67% | 177 | 509 | -65.23% |
| 2023/02 | 128 | 68 | 212.20% | 88.24% | 169 | 506 | -66.60% |
| 2023/01 | 41 | 438 | -78.53% | -90.64% | 41 | 438 | -90.64% |
| 2022/12 | 191 | 140 | 1023.53% | 36.43% | 2,177 | 872 | 149.66% |
| 2022/11 | 17 | 438 | -89.17% | -96.12% | 1,986 | 732 | 171.31% |
| 2022/10 | 157 | 219 | 16.30% | -28.31% | 1,969 | 294 | 569.73% |
| 2022/09 | 135 | 0 | 25.00% | - | 1,812 | 75 | 2316.00% |
| 2022/08 | 108 | 75 | -79.11% | 44.00% | 1,677 | 75 | 2136.00% |
| 2022/07 | 517 | 0 | 14.63% | - | 1,569 | 0 | - |
| 2022/06 | 451 | 0 | 436.90% | - | 1,052 | 0 | - |
| 2022/05 | 84 | 0 | 950.00% | - | 601 | 0 | - |
| 2022/04 | 8 | 0 | 166.67% | - | 517 | 0 | - |
| 2022/03 | 3 | 0 | -95.59% | - | 509 | 0 | - |
| 2022/02 | 68 | 0 | -84.47% | - | 506 | 0 | - |
| 2022/01 | 438 | 0 | 212.86% | - | 438 | 0 | - |
| 2021/12 | 140 | 0 | -68.04% | - | 872 | 0 | - |
| 2021/11 | 438 | 0 | 100.00% | - | 732 | 0 | - |
| 2021/10 | 219 | 0 | - | - | 294 | 0 | - |
| 2021/09 | 0 | 0 | -100.00% | - | 75 | 0 | - |
| 2021/08 | 75 | 0 | - | - | 75 | 0 | - |
| 2021/07 | 0 | 0 | - | - | 0 | 0 | - |
| 2021/06 | 0 | 0 | - | - | 0 | 0 | - |
| 2021/05 | 0 | 0 | - | - | 0 | 0 | - |
| 2021/04 | 0 | 0 | - | - | 0 | 0 | - |
| 2021/03 | 0 | 0 | - | - | 0 | 0 | - |
| 2021/02 | 0 | 0 | - | - | 0 | 0 | - |
| 2021/01 | 0 | 0 | - | - | 0 | 0 | - |
| 2020/12 | 0 | 0 | - | - | 0 | 0 | - |
| 2020/11 | 0 | 0 | - | - | 0 | 0 | - |
| 2020/10 | 0 | 0 | - | - | 0 | 0 | - |